Unknown NA INTERVENTIONAL 2-arm NCT04488458

Susceptibility Testing of Biofilm to Guide Treatment of Periprosthetic Joint Infections

Treatment of Periprosthetic Joint Infections Guided by Minimum Biofilm Eradication Concentration (MBEC) in Addition to Minimum Inhibitory Concentration (MIC); a Prospective Randomized Clinical Trial

Sponsor: Göteborg University

Conditions Hip Prosthesis Infection Knee Prosthesis Infection Prosthetic Infection Prosthetic Joint Infection

Interventions MIC or MBEC+MIC based treatment algorithm

Updated 6 times since 2020 Last updated: Aug 18, 2021 Started: Aug 15, 2021 Primary completion: Dec 31, 2022 Completion: Dec 31, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04488458, this NA trial focuses on Hip Prosthesis Infection and Knee Prosthesis Infection and remains ongoing. Sponsored by Göteborg University, it has been updated 6 times since 2021, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Feb 2024 — Jul 2024 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Sep 2021 — Feb 2024 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Jan 2021 — Sep 2021 [monthly]

Not Yet Recruiting NA

▶ Show 1 earlier version

Aug 2020 — Jan 2021 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Göteborg University
Vastra Gotaland Region

Data source: Vastra Gotaland Region

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Mölndal, Sweden